{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T00:53:47Z","timestamp":1759366427227,"version":"build-2065373602"},"reference-count":23,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"am","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Revue de M\u00e9decine Interne"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.revmed.2022.08.003","type":"journal-article","created":{"date-parts":[[2022,9,7]],"date-time":"2022-09-07T23:27:08Z","timestamp":1662593228000},"page":"645-648","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["C\u0153ur et m\u00e9decine interne\u00a0: lupus syst\u00e9mique et syndrome des antiphospholipides"],"prefix":"10.1016","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7811-3684","authenticated-orcid":false,"given":"N.","family":"Morel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Le Guern","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Mouthon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.-C.","family":"Piette","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Costedoat-Chalumeau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.revmed.2022.08.003_bib0120","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1191\/0961203305lu2200oa","article-title":"Cardiac involvement in systemic lupus erythematosus","volume":"14","author":"Doria","year":"2005","journal-title":"Lupus"},{"issue":"8","key":"10.1016\/j.revmed.2022.08.003_bib0125","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1002\/art.34473","article-title":"Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus","volume":"64","author":"Petri","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"9","key":"10.1016\/j.revmed.2022.08.003_bib0130","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1002\/art.40930","article-title":"2019 European League Against Rheumatism\/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus","volume":"71","author":"Aringer","year":"2019","journal-title":"Arthritis Rheumatol"},{"issue":"5","key":"10.1016\/j.revmed.2022.08.003_bib0135","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/01.md.0000091181.93122.55","article-title":"Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1000 patients","volume":"82","author":"Cervera","year":"2003","journal-title":"Medicine"},{"issue":"3","key":"10.1016\/j.revmed.2022.08.003_bib0140","first-page":"e4166","article-title":"Pericarditis in lupus","volume":"11","author":"Dein","year":"2019","journal-title":"Cureus"},{"issue":"1","key":"10.1016\/j.revmed.2022.08.003_bib0145","doi-asserted-by":"crossref","first-page":"e000221","DOI":"10.1136\/lupus-2017-000221","article-title":"Associates and predictors of pleurisy or pericarditis in SLE","volume":"4","author":"Ryu","year":"2017","journal-title":"Lupus Sci Med"},{"issue":"14","key":"10.1016\/j.revmed.2022.08.003_bib0150","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1177\/0961203315593169","article-title":"Colchicine: a simple and effective treatment for pericarditis in systemic lupus erythematosus? A report of 10 cases","volume":"24","author":"Morel","year":"2015","journal-title":"Lupus"},{"issue":"14","key":"10.1016\/j.revmed.2022.08.003_bib0155","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1136\/heartjnl-2011-301306","article-title":"Efficacy and safety of colchicine for pericarditis prevention. Systematic review and meta-analysis","volume":"98","author":"Imazio","year":"2012","journal-title":"Heart"},{"issue":"6","key":"10.1016\/j.revmed.2022.08.003_bib0160","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/0002-8703(85)90023-7","article-title":"Cardiovascular manifestations of systemic lupus erythematosus","volume":"110","author":"Doherty","year":"1985","journal-title":"Am Heart J"},{"issue":"1","key":"10.1016\/j.revmed.2022.08.003_bib0165","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3899\/jrheum.160493","article-title":"Lupus myocarditis: initial presentation and long-term outcomes in a multicentric series of 29 patients","volume":"44","author":"Thomas","year":"2017","journal-title":"J Rheumatol"},{"issue":"2","key":"10.1016\/j.revmed.2022.08.003_bib0170","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1097\/01.rhu.0000111317.80408.16","article-title":"Coronary vasculitis with acute myocardial infarction in a young woman with systemic lupus erythematosus","volume":"10","author":"Caracciolo","year":"2004","journal-title":"J Clin Rheumatol"},{"issue":"3","key":"10.1016\/j.revmed.2022.08.003_bib0175","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/FJC.0b013e31829dd857","article-title":"Atherosclerosis in systemic lupus erythematosus","volume":"62","author":"Stojan","year":"2013","journal-title":"J Cardiovasc Pharmacol"},{"issue":"6","key":"10.1016\/j.revmed.2022.08.003_bib0180","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1136\/annrheumdis-2013-204838","article-title":"Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients","volume":"74","author":"Cervera","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"10.1016\/j.revmed.2022.08.003_bib0185","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1253\/circj.69.1290","article-title":"Antiphospholipid syndrome presenting as intracardiac thrombus with pulmonary embolism","volume":"69","author":"Ye","year":"2005","journal-title":"Circ J"},{"key":"10.1016\/j.revmed.2022.08.003_bib0190","article-title":"Syndrome des antiphospholipides","author":"Costedoat-Chalumeau","year":"2018","journal-title":"EMC - Appareil locomoteur"},{"issue":"4","key":"10.1016\/j.revmed.2022.08.003_bib0195","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1002\/art.10187","article-title":"Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1000 patients","volume":"46","author":"Cervera","year":"2002","journal-title":"Arthritis Rheum"},{"issue":"12","key":"10.1016\/j.revmed.2022.08.003_bib0200","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/j.autrev.2016.09.010","article-title":"Catastrophic antiphospholipid syndrome (CAPS): descriptive analysis of 500 patients from the International CAPS Registry","volume":"15","author":"Rodriguez-Pinto","year":"2016","journal-title":"Autoimmun Rev"},{"issue":"7","key":"10.1016\/j.revmed.2022.08.003_bib0205","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1177\/0961203320914363","article-title":"Catastrophic antiphospholipid syndrome following the introduction of rivaroxaban","volume":"29","author":"Stammler","year":"2020","journal-title":"Lupus"},{"key":"10.1016\/j.revmed.2022.08.003_bib0210","first-page":"112","volume":"218","author":"Iqubal","year":"2019","journal-title":"Molecular mechanism involved in cyclophosphamide-induced cardiotoxicity: old drug with a new vision. Life Sci"},{"issue":"5","key":"10.1016\/j.revmed.2022.08.003_bib0215","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1182\/blood.V68.5.1114.1114","article-title":"Cyclophosphamide cardiotoxicity: an analysis of dosing as a risk factor","volume":"68","author":"Goldberg","year":"1986","journal-title":"Blood"},{"issue":"5s1","key":"10.1016\/j.revmed.2022.08.003_bib0220","doi-asserted-by":"crossref","first-page":"105316","DOI":"10.1016\/j.jbspin.2021.105316","article-title":"Practical management of patients on hydroxychloroquine","volume":"88","author":"Richez","year":"2021","journal-title":"Joint Bone Spine"},{"issue":"2","key":"10.1016\/j.revmed.2022.08.003_bib0225","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1159\/000094079","article-title":"Cardiomyopathy related to antimalarial therapy with illustrative case report","volume":"107","author":"Costedoat-Chalumeau","year":"2006","journal-title":"Cardiology"},{"issue":"5","key":"10.1016\/j.revmed.2022.08.003_bib0115","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.revmed.2020.04.006","article-title":"A rare cause of impaired general condition: muscular and cardiac toxicity of antimalarials","volume":"41","author":"Lenfant","year":"2020","journal-title":"Rev Med Interne"}],"container-title":["La Revue de M\u00e9decine Interne"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866322006075?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866322006075?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:45:27Z","timestamp":1759337127000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0248866322006075"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":23,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["S0248866322006075"],"URL":"https:\/\/doi.org\/10.1016\/j.revmed.2022.08.003","relation":{},"ISSN":["0248-8663"],"issn-type":[{"type":"print","value":"0248-8663"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"C\u0153ur et m\u00e9decine interne\u00a0: lupus syst\u00e9mique et syndrome des antiphospholipides","name":"articletitle","label":"Article Title"},{"value":"La Revue de M\u00e9decine Interne","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.revmed.2022.08.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Soci\u00e9t\u00e9 Nationale Fran\u00e7aise de M\u00e9decine Interne (SNFMI). Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}